At the UN Security Council, India fiercely condemned Pakistan for blocking Afghan trade and launching deadly airstrikes that killed 372 civ...

British drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...

West Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.

Diving into old group chats is like flipping through a scrapbook of memories, revealing pieces of the person we used to be. These digital i...

The Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...

Hexagon Nutrition’s Rs 139 crore IPO saw strong retail demand on Day 2, with the retail portion subscribed 2.43 times. The grey market prem...

Hexagon Nutrition's IPO opened strongly on its first day. Retail investors showed significant interest, subscribing 62% of their quota. The...

As therapy-related language becomes increasingly common, many people are questioning whether knowing mental health terminology automaticall...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...

The oral drug, pociredir, was being tested ⁠to treat sickle-cell ⁠disease, an inherited blood disorder that can trigger pain, anemia and or...

Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...

The Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...

Sir H.N. Reliance Foundation Hospital has been ranked the country's leading multi-specialty institution in the Times of India Critical Care...

Supriya Lifescience shares jumped over 16% after the company posted a strong Q4FY26 performance, with PAT rising 47% YoY and revenue surgin...

Zydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...